Indicating that the upregulation of DLX1 and PRMT3 transcription may occur in later disease stages, DLX-1 and PRMT3 mRNA levels were merely elevated in R6/2 mice but not in YAC128 mice that show a less severe HD phenotype than R6/2 mice. The gene discussed is DLX1; the disease is Huntington disease.